Engineered Red Cell Therapeutics (RCT) as Artificial Antigen Presenting Cells Promote and Antitumor Activity of Antigen Specific T Cells

Xuqing Zhang, Shamael R. Dastagir, Naren Subbiah, Mengyao Luo, Vikram Soman, Sneha Pawar, Douglas C. McLaughlin, Nicholas Bayhi, Viral Amin, Torben Straight Nissen, Christopher L. Carpenter, Thomas J. Wickham, Lori Melançon, and Tiffany F. Chen. Poster presented at the American Association for Cancer Research (AACR) annual meeting on April 2, 2019, Atlanta, GA